Cargando…
Penicillin allergy evaluation in hospitalized patients with hematologic malignancy
A penicillin allergy testing service (PATS) assessed penicillin allergy in patients with hematologic malignancies; 17 patients who met criteria had negative skin testing. Patients who underwent penicillin challenge passed and were delabeled. Of delabeled patients, 87% received and tolerated β-lactam...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cambridge University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204135/ https://www.ncbi.nlm.nih.gov/pubmed/37228506 http://dx.doi.org/10.1017/ash.2023.144 |
| _version_ | 1785045772483428352 |
|---|---|
| author | Patel, Vima M. Chu, Brian Hamilton, Keith W. Bellamy, Cassandra Harker, Christina Bryer, Joshua S. Shields, Bridget Hirsh, Rebecca L. Fadugba, Olajumoke O. Micheletti, Robert G. |
| author_facet | Patel, Vima M. Chu, Brian Hamilton, Keith W. Bellamy, Cassandra Harker, Christina Bryer, Joshua S. Shields, Bridget Hirsh, Rebecca L. Fadugba, Olajumoke O. Micheletti, Robert G. |
| author_sort | Patel, Vima M. |
| collection | PubMed |
| description | A penicillin allergy testing service (PATS) assessed penicillin allergy in patients with hematologic malignancies; 17 patients who met criteria had negative skin testing. Patients who underwent penicillin challenge passed and were delabeled. Of delabeled patients, 87% received and tolerated β-lactams during follow-up. Providers found the PATS valuable. |
| format | Online Article Text |
| id | pubmed-10204135 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Cambridge University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102041352023-05-24 Penicillin allergy evaluation in hospitalized patients with hematologic malignancy Patel, Vima M. Chu, Brian Hamilton, Keith W. Bellamy, Cassandra Harker, Christina Bryer, Joshua S. Shields, Bridget Hirsh, Rebecca L. Fadugba, Olajumoke O. Micheletti, Robert G. Antimicrob Steward Healthc Epidemiol Concise Communication A penicillin allergy testing service (PATS) assessed penicillin allergy in patients with hematologic malignancies; 17 patients who met criteria had negative skin testing. Patients who underwent penicillin challenge passed and were delabeled. Of delabeled patients, 87% received and tolerated β-lactams during follow-up. Providers found the PATS valuable. Cambridge University Press 2023-05-16 /pmc/articles/PMC10204135/ /pubmed/37228506 http://dx.doi.org/10.1017/ash.2023.144 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. |
| spellingShingle | Concise Communication Patel, Vima M. Chu, Brian Hamilton, Keith W. Bellamy, Cassandra Harker, Christina Bryer, Joshua S. Shields, Bridget Hirsh, Rebecca L. Fadugba, Olajumoke O. Micheletti, Robert G. Penicillin allergy evaluation in hospitalized patients with hematologic malignancy |
| title | Penicillin allergy evaluation in hospitalized patients with hematologic malignancy |
| title_full | Penicillin allergy evaluation in hospitalized patients with hematologic malignancy |
| title_fullStr | Penicillin allergy evaluation in hospitalized patients with hematologic malignancy |
| title_full_unstemmed | Penicillin allergy evaluation in hospitalized patients with hematologic malignancy |
| title_short | Penicillin allergy evaluation in hospitalized patients with hematologic malignancy |
| title_sort | penicillin allergy evaluation in hospitalized patients with hematologic malignancy |
| topic | Concise Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204135/ https://www.ncbi.nlm.nih.gov/pubmed/37228506 http://dx.doi.org/10.1017/ash.2023.144 |
| work_keys_str_mv | AT patelvimam penicillinallergyevaluationinhospitalizedpatientswithhematologicmalignancy AT chubrian penicillinallergyevaluationinhospitalizedpatientswithhematologicmalignancy AT hamiltonkeithw penicillinallergyevaluationinhospitalizedpatientswithhematologicmalignancy AT bellamycassandra penicillinallergyevaluationinhospitalizedpatientswithhematologicmalignancy AT harkerchristina penicillinallergyevaluationinhospitalizedpatientswithhematologicmalignancy AT bryerjoshuas penicillinallergyevaluationinhospitalizedpatientswithhematologicmalignancy AT shieldsbridget penicillinallergyevaluationinhospitalizedpatientswithhematologicmalignancy AT hirshrebeccal penicillinallergyevaluationinhospitalizedpatientswithhematologicmalignancy AT fadugbaolajumokeo penicillinallergyevaluationinhospitalizedpatientswithhematologicmalignancy AT michelettirobertg penicillinallergyevaluationinhospitalizedpatientswithhematologicmalignancy |